Back to Top Skip to main content Skip to sub-navigation

DoD Leverages GEIS Respiratory Surveillance to Respond to COVID-19

Three men in a pig pen taking samples Staff from the U.S. Navy Medical Research Unit 6, better known as NAMRU-6, perform sampling on swine and swine workers in Peru. This testing helps monitor the transmission of potential respiratory pathogens.

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus

As the COVID-19 pandemic emerged and spread around the world, the Department of Defense funded health surveillance activities to rapidly support military forces living and working in the U.S. and abroad. Armed Forces Health Surveillance Branch’s Global Emerging Infection Surveillance (GEIS) program manages a global laboratory network and uses analytical processes to detect emergent diseases and track respiratory illnesses such as influenza.

This GEIS-supported respiratory network, comprised of partnerships with Army, Navy, and Air Force public health and medical research laboratories, includes hundreds of surveillance sites in over 30 countries.

These surveillance locations are selected based on inputs from the regional laboratories and in coordination with the Geographic Combatant Commands. GEIS also funds and maintains surveillance of DoD Service members through the DoD Global Respiratory Pathogen Surveillance Program, which tests samples from over 100 sentinel site locations and is operated by the U.S. Air Force School of Aerospace Medicine. In addition, GEIS supports recruit and ship-board surveillance activities operated by Naval Health Research Center. Respiratory pathogens, bacteria and viruses that can cause diseases, present a unique challenge for recruit and ship-board populations due to their close living conditions and activities that can enable the rapid spread of infections and significantly impact force readiness.

“GEIS-funded surveillance provides the foundation for rapid testing so that a better understanding of the incidence and spread of SARS-CoV-2 virus can be established,” said U.S. Public Health Service Cmdr. (Dr.) Mark Scheckelhoff, lead for the GEIS Respiratory Infections portfolio. “Through the long-term investments to build and maintain this network of laboratory locations, we have an extensive analytical capability. GEIS has enabled our partners to respond to the ongoing pandemic and detect the presence of SARS-CoV-2 around the world.”

Through GEIS support, laboratory partners conduct many investigations including the sampling of animal markets and farm locations in four countries. These efforts include sampling of avian and swine species, as well as the workers at a particular location. Samples are then analyzed for novel influenza or other emerging pathogens with pandemic potential. 

Each laboratory within the network is able to perform highly sensitive and specific testing on respiratory samples and together process approximately 30,000 samples per year. These samples are collected in various clinics and military medical treatment facilities from individuals presenting with influenza-like-illness (ILI) symptoms.

“Due to the COVID-19 pandemic, the number of samples analyzed for the 2019-2020 season remains to be determined, but over 45,000 analytical tests on ILI samples have already been performed,” stated Army Lt. Col. (Dr.) Kevin Taylor, GEIS focus area chief.

GEIS coordinates closely with the Centers for Disease Control and Prevention and other partners to ensure the data is shared. They also present annual influenza data from DoD populations to the Food and Drug Administration, to help determine the composition of the seasonal influenza vaccine for the United States.

“GEIS coordinates information sharing activities related to the development of countermeasures, vaccines, and other interventions to support the ongoing pandemic and place the network in a good position to address future threats,” said Navy Capt. Guillermo Pimentel.

You also may be interested in...

Global Influenza Summary: October 2, 2016

Report
10/2/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSB Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: September 3, 2016

Report
9/3/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSB Reports and Publications | Influenza Summary and Reports

Preserving the Health of U.S. Armed Forces with DMSS and DoDSR

Infographic
7/13/2016
The Defense Medical Surveillance System (DMSS) and the DoD Serum Repository (DoDSR) provide unprecedented capabilities for conducting comprehensive population-based surveillance of the U.S. Armed Forces while protecting the privacy and confidentiality of service members. The systems together provide glimpses of the capabilities and potential uses of public health surveillance systems of the future.  The research advantages of the DMSS and DoDSR The DMSS and DoDSR enable researchers to focus time and attention on solving methodological problems, interpreting results, producing summaries and reports.  DMSS includes personnel data, medical data, laboratory data, deployment data, and DoDSR data. Benefactors of the DMSS and DoDSR are epidemiologists, preventive medicine doctors, data analysts, DoD policy makers, Military Commanders and public health officers. Learn how to harness the full value of the DMSS and DoDSR at www.Health.mil/AFHSB

The Defense Medical Surveillance System (DMSS) and the DoD Serum Repository (DoDSR) provide unprecedented capabilities for conducting comprehensive population-based surveillance of the U.S. Armed Forces.

Recommended Content:

Armed Forces Health Surveillance Division | Defense Medical Surveillance System | DoD Serum Repository

HIV and AIDS in the U.S. Military

Infographic
6/27/2016
June 27th is National HIV Testing Day. HIV-1 infection is a major health importance for the U.S. military. Since the start of HIV-1 military health surveillance analysis during 1990-2013, service members diagnosed with the HIV-1 infection in recent years have remained longer in U.S. Armed Forces.  There were a total of 5,227 new diagnoses in 24-years of surveillance. The August 2015 Medical Surveillance Monthly Report (MSMR) reported that “Estimated median durations of service after initial HIV-1 diagnoses ranged from 2.29 years in Cohort 1 ( 1990-1994) to 3.65 years in Cohort 4 (2005-2009). Thus, in the 15 years between 1990-1994 and 2005-2009, the median durations of service after HIV-1 diagnoses increased by 1.4 years.” Factors contributing to longer service include: •	Availability and effectiveness of HIV treatments •	Decline in stigmas associated with diagnosis of the HIV infection •	Changes in U.S. military policy that allow the LGBT community to serve in its ranks  Note: Service members who are diagnosed with HIV-1 infections, regardless of their sexual orientations, may elect to continue their military service careers.  Get tested today – it’s the only way to know. Early HIV testing helps to prevent transmission and lowers the risk of severe health complications. Follow us on Twitter for more information: @AFHSBPAGE  Also on Twitter: National HIV Testing Day #NHTD

June 27th is National HIV Testing Day. HIV-1 infection is a major health importance for the U.S. military. Since the start of HIV-1 military health surveillance analysis during 1990-2013, service members diagnosed with the HIV-1 infection in recent years have remained longer in U.S. Armed Forces.

Recommended Content:

Armed Forces Health Surveillance Division | HIV/AIDS Prevention and Treatment

Global Influenza Summary: June 5, 2016

Report
6/5/2016

Global Influenza Summary: June 05, 2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSB Reports and Publications | Influenza Summary and Reports

The HPV Vaccine Saves Lives

Infographic
5/16/2016
The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4). This graphic highlights information the benefits of the HPV vaccine. The vaccine is most effective among fully vaccinated individuals.   Cancer Prevention Facts •	HPV is the most common sexually  transmitted infection (STI) •	There are more than 40 HPV types that can infect the genital areas •	Some HPV types give warts •	Some HPV types develop cancer  Effective Against STI Transmission •	The HPV vaccine is a safe and effective way to protect yourself from the virus •	The HPV vaccine provides nearly 100% protection from HPV types 6,11,16 and 18 •	HPV vaccine shows early signs of success in reducing HPV infections and related illnesses •	Protection is expected to be long-lasting  Safety Tips •	Getting your HPV vaccine and practicing safe sex such as wearing a condom may lower the risk of HPV •	Limiting the number of lifetime sex partners can also lower the risk of HPV •	When given the HPV vaccine, the body makes antibodies in response to the protection to clear it from the body  Get the Facts •	2,091 female service members aged 17-26 years received 1-3 HPV4 doses during 2006-2012, stratified by number of doses (1, 2, or 3).  Get the HPV Vaccine •	Only 22.5% of eligible service members initiated the series •	Of those, only 39.1% completed the full three-dose series as of June 2011.  Even though the 3 dose regiment provides nearly complete protection against HPV16 and HPV18, in the U.S., only 12% and 19% of female adolescents among commercial and Medicaid plans respectively complete the series.  Read HPV Facts from the CDC: https://www.ok.gov/health2/documents/IMM_Teens_HPV_Facts.pdf  Read the STI issue of the Medical Surveillance Monthly Report at Health.Mil/MSMR   Get the conversation started. Ask your healthcare provider about the HPV vaccine today. Follow us on Twitter @AFHSBPAGE and use hashtag #VaccinesWork.

The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4).

Recommended Content:

Medical and Dental Preventive Care Fitness | Immunizations | Men's Health | Human Papillomavirus | Armed Forces Health Surveillance Division | Women's Health

Study Finds Strong Immune Response to HPV Vaccine Among Female Service Members

Report
5/11/2016

A new study of female service members that examined their immune response to a vaccine to combat the sexually transmitted virus that causes cervical cancer showed development of antibodies in 80 to 99 percent of recipients against each of the four strains of the disease.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Public Health | Armed Forces Health Surveillance Division | Medical and Dental Preventive Care Fitness

MSMR Vol. 23 No. 7 - July 2016

Report
1/1/2016

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Increasing severity of traumatic brain injury is associated with an increased risk of subsequent headache or migraine: a retrospective cohort study of U.S. active duty service members, 2006–2015; Use of complementary health approaches at military treatment facilities, active component, U.S. Armed Forces, 2010–2015; Incident diagnoses of cancers in the active component and cancer-related deaths in the active and reserve components, U.S. Armed Forces, 2005–2014.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Public Health

MSMR Vol. 23 No. 4 - April 2016

Report
1/1/2016

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Absolute and relative morbidity burdens attributable to various illnesses and injuries, active component, U.S. Armed Forces, 2015; Hospitalizations among members of the active component, U.S. Armed Forces, 2015; Ambulatory visits among members of the active component, U.S. Armed Forces, 2015; Surveillance snapshot: Illness and injury burdens, reserve component, U.S. Armed Forces, 2015; Surveillance snapshot: Illness and injury burdens, recruit trainees, active component, U.S. Armed Forces, 2015; Absolute and relative morbidity burdens attributable to various illnesses and injuries, non-service member beneficiaries of the Military Health System, 2015.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Public Health

MSMR Vol. 23 No. 3 - March 2016

Report
1/1/2016

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: The DoD Global, Laboratory-based, Influenza Surveillance Program: summary for the 2013-2014 influenza season; Correlation between antimicrobial resistance in Escherichia coli infections in hospitalized patients and rates of inpatient prescriptions for selected antimicrobial agents, Department of Defense hospitals, 2010-2014; Brief report: The epidemiology of herpes simplex virus type 2 infections in a large cohort of HIV-infected patients, 2006-2014; Update: Heat injuries, active component, U.S. Army, Navy, Air Force, and Marine Corps, 2015; Update: Exertional rhabdomyolysis, active component, U.S. Army, Navy, Air Force, and Marine Corps, 2011-2015; Update: Exertional hyponatremia, active component, U.S. Army, Navy, Air Force, and Marine Corps, 2000-2015.

Recommended Content:

Health Readiness | Public Health | Armed Forces Health Surveillance Division

Armed Forces Health Surveillance Center Annual Report

Report
12/15/2015

In this annual report, you will see that the Armed Forces Health Surveillance Center continued to make significant strides in supporting public health surveillance for the Department of Defense to maintain the health and readiness of its forces, and contribute to the global health security of its allies.

Recommended Content:

Armed Forces Health Surveillance Division | AFHSB Reports and Publications
<< < ... 41 42 43 44 45 > >> 
Showing results 661 - 671 Page 45 of 45

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.